Rapid Laboratories Inc.
1 clinical trials · Sponsor
◉ Watch Rapid Laboratories Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs) (NCT00951743) | Rapid Laboratories Inc. | 2009-07-01 |
Track Rapid Laboratories Inc. automatically
Every clearance here is in the API, with alerts when new ones post.